Literature DB >> 18480852

Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid.

M Stiborová1, E Frei, H H Schmeiser.   

Abstract

Ingestion of aristolochic acid (AA) is associated with the development of AA-nephropathy and Balkan endemic nephropathy, which are characterized by chronic renal failure, tubulointerstitial fibrosis, and urothelial cancer. Understanding which enzymes are involved in AA activation and/or detoxification is important in assessing susceptibility to AA. Xiao et al. demonstrate that hepatic cytochrome P450s in mice detoxicate AA and thereby protect kidney from injury. The relative contribution of enzymes activating AA to induce urothelial cancer in humans remains to be resolved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480852     DOI: 10.1038/ki.2008.125

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Aristolochic acid I metabolism in the isolated perfused rat kidney.

Authors:  Horacio A Priestap; M Cecilia Torres; Robert A Rieger; Kathleen G Dickman; Tomoko Freshwater; David R Taft; Manuel A Barbieri; Charles R Iden
Journal:  Chem Res Toxicol       Date:  2011-12-14       Impact factor: 3.739

2.  A fluorescence-based analysis of aristolochic acid-derived DNA adducts.

Authors:  Victor Romanov; Victoria Sidorenko; Thomas A Rosenquist; Terry Whyard; Arthur P Grollman
Journal:  Anal Biochem       Date:  2012-04-04       Impact factor: 3.365

3.  Comparative study of the contents of analogues of aristolochic acid in two kinds of Aristolochiae Fructus by high-performance liquid chromatography.

Authors:  Yu-Qiong Xu; Xiao-Wei Li; Guang-Xue Liu; Xuan Wang; Ming-Ying Shang; Xiao-Mei Li; Shao-Qing Cai
Journal:  J Nat Med       Date:  2012-04-08       Impact factor: 2.343

Review 4.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

5.  Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling.

Authors:  Marie Stiborova
Journal:  J Vis Exp       Date:  2018-03-20       Impact factor: 1.355

6.  Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers.

Authors:  Marie Stiborová; Jiří Hudeček; Eva Frei; Heinz H Schmeiser
Journal:  Interdiscip Toxicol       Date:  2008-06

Review 7.  «Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins.

Authors:  Stjepan Pepeljnjak; Maja Šegvić Klarić
Journal:  Toxins (Basel)       Date:  2010-06-11       Impact factor: 4.546

8.  Aristolochic acid I promoted clonal expansion but did not induce hepatocellular carcinoma in adult rats.

Authors:  Yong-Zhen Liu; Heng-Lei Lu; Xin-Ming Qi; Guo-Zhen Xing; Xin Wang; Pan Yu; Lu Liu; Fang-Fang Yang; Xiao-Lan Ding; Ze-An Zhang; Zhong-Ping Deng; Li-Kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2021-03-08       Impact factor: 7.169

9.  A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.

Authors:  Marie Stiborová; František Bárta; Kateřina Levová; Petr Hodek; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

Review 10.  Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches.

Authors:  Marie Stiborová; Eva Frei; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.